A Glutathione Precursor Reduces Oxidative Injury to Cultured Embryonic Cardiomyocytes

Area of Science:

• Cardiovascular Research
• Oxidative Stress Biology
• Neonatal Medicine

Background:

• Newborn infants face significant risks from oxidative stress, particularly after birth asphyxia.
• Ischemia-reperfusion injury following asphyxia can cause severe brain and heart damage, leading to mortality or long-term disability.

Purpose of the Study:

• To assess the protective effects of gamma-L-glutamyl-L-cysteine (γGlu-Cys), a glutathione precursor, against oxidative injury in cultured embryonic cardiomyocytes (H9c2 cells).

Main Methods:

• H9c2 cells were subjected to 6-hour ischemia followed by 2-hour reperfusion, with or without 0.5 mM γGlu-Cys treatment.
• Oxidative stress and apoptosis were quantified by measuring lactate dehydrogenase (LDH) release, cytosolic cytochrome c levels, and secondary lysosome formation via electron microscopy.

Main Results:

• γGlu-Cys treatment significantly reduced LDH release (P=0.02) and secondary lysosome formation (P=0.01) compared to untreated controls.
• The protective effect of γGlu-Cys on LDH release was comparable to that of a caspase inhibitor (P=0.67).
• A significant increase in cytosolic cytochrome c post-reperfusion (P=0.01) was observed, further supporting γGlu-Cys's anti-apoptotic action.

Conclusions:

• Gamma-L-glutamyl-L-cysteine (γGlu-Cys) demonstrates significant protective capabilities for cultured embryonic cardiomyocytes against apoptosis induced by oxidative injury.
• γGlu-Cys acts as an effective antioxidant, mitigating damage associated with ischemia-reperfusion events in cardiac cells.